Melinda Mast
About Melinda Mast
Melinda Mast is the Executive Director of Cell Therapy Global Patient Operations at Bristol Myers Squibb, with over 15 years of experience in autologous cellular therapy operations.
Current Position at Bristol Myers Squibb
Melinda Mast currently serves as the Executive Director of Cell Therapy Global Patient Operations at Bristol Myers Squibb. She is based in Seattle, Washington, United States. In this role, she provides strategic and operational leadership for a team of over 80 people globally, overseeing the Global Patient Operations system. This includes managing new patient enrollment, treatment scheduling, Chain of Identity, autologous cell collection, product order placement, and in-transit tracking for autologous immunotherapy treatments.
Professional Experience at Juno Therapeutics
Before her role at Bristol Myers Squibb, Melinda Mast worked at Juno Therapeutics, Inc. She held the position of Executive Director of Cell Therapy Global Patient Operations for 9 months in 2019. Additionally, she served as Director/Senior Director of Patient Operations from 2014 to 2019, where she was responsible for overseeing apheresis network operations, scheduling, and cell logistics. Her time at Juno Therapeutics contributed significantly to her expertise in cell therapy operations.
Roles at Dendreon Corporation
Melinda Mast's experience at Dendreon spanned several roles over the years. She served as Associate Director/Director of Apheresis Operations from 2011 to 2013 and as Sr. Manager of Corporate Operations from 2009 to 2011. Prior to these roles, she worked as a Quality Assurance Supervisor from 2007 to 2009 and as Senior QA Associate from 2005 to 2007. Her diverse roles at Dendreon provided her with comprehensive experience in quality assurance and corporate operations within the cell therapy industry.
Early Career at CTI BioPharma
Melinda Mast's early career includes significant time at CTI BioPharma, where she served as a GMP/GLP Compliance Auditor from 2004 to 2005 and as Senior Bioanalytical Chemist/Study Monitor from 1997 to 2004. These roles marked the beginning of her journey in the biopharmaceutical industry, allowing her to gain valuable insights into compliance auditing and bioanalytical chemistry.
Educational Background
Melinda Mast holds a Certificate in Sustainable Business from Bainbridge Graduate Institute, which she earned from 2008 to 2009. She also obtained a Bachelor of Science degree in Environmental Health from Colorado State University, where she studied from 1985 to 1990. Her educational background has helped shape her approach to sustainable practices and environmental health within the cell therapy and biopharmaceutical sectors.